Abstract: In one embodiment, a network boot program is received from a server via a first network interface controller associated with a first network identifier. The network boot program is executed. An operating system loader comprising an operating system driver is received from the server via the first network interface controller. The operating system driver identifies a second network interface controller associated with a second network identifier. The operating system driver associates the first network interface controller with the second network identifier and associates the second network interface controller with the first network identifier.

Abstract: In one embodiment, a network boot program is received from a server via a first network interface controller associated with a first network identifier. The network boot program is executed. An operating system loader comprising an operating system driver is received from the server via the first network interface controller. The operating system driver identifies a second network interface controller associated with a second network identifier. The operating system driver associates the first network interface controller with the second network identifier and associates the second network interface controller with the first network identifier.

Abstract: In one embodiment, a network boot program is received from a server via a first network interface controller associated with a first network identifier. The network boot program is executed. An operating system loader comprising an operating system driver is received from the server via the first network interface controller. The operating system driver identifies a second network interface controller associated with a second network identifier. The operating system driver associates the first network interface controller with the second network identifier and associates the second network interface controller with the first network identifier.

Abstract: The present invention relates to a new streptavidin muteins. This mutein is binds both streptavidin binding peptide tagged and biotin or biotinylated molecules, and does so in a reversible fashion. As such, it is stable enough to allow reuse, and producible with reasonable production yield via secretion in a soluble functional state without the requirement of refolding via the tedious and expensive denaturation and renaturation processes.

Abstract: In one embodiment, a network boot program is received from a server via a first network interface controller associated with a first network identifier. The network boot program is executed. An operating system loader comprising an operating system driver is received from the server via the first network interface controller. The operating system driver identifies a second network interface controller associated with a second network identifier. The operating system driver associates the first network interface controller with the second network identifier and associates the second network interface controller with the first network identifier.

Abstract: The present invention relates to a new streptavidin muteins. This mutein is binds both streptavidin binding peptide tagged and biotin or biotinylated molecules, and does so in a reversible fashion. As such, it is stable enough to allow reuse, and producible with reasonable production yield via secretion in a soluble functional state without the requirement of refolding via the tedious and expensive denaturation and renaturation processes.

Abstract: The present invention relates to a new streptavidin muteins. This mutein is The muteins are capable of oligomerization to form tetramers, with relatively strong subunit interactions, dissociation constant (KD) for biotin in this mutein in the range of 10?7 to 10?8M, off-rate (koff) for the bound biotin in the streptavidin-biotin complex in the range of 10?4 sec?1, stable enough to allow reuse, and producible producable with reasonable production yield via secretion in a soluble functional state without the requirement of refolding streptavidin via the tedious and expensive denaturation and renaturation processes.

Abstract: The present invention relates to a new streptavidin muteins. This mutein is The muteins are capable of oligomerization to form tetramers, with relatively strong subunit interactions, dissociation constant (KD) for biotin in this mutein in the range of 10?7 to 10?8M, off-rate (koff) for the bound biotin in the streptavidin-biotin complex in the range of 10?4 sec?1, stable enough to allow reuse, and producible producable with reasonable production yield via secretion in a soluble functional state without the requirement of refolding streptavidin via the tedious and expensive denaturation and renaturation processes.

Abstract: Tone detection includes receiving a series of frames having a signal containing a tone and locating a first frame in the series of frames in which there is at least a partial, tone. The signal energy of the first frame may then be compared to the signal energy of a full tone frame or compared to the signal energy of a frame. A start time of the tone in the signal may then be determined. An end time of the tone in the signal may be determined by locating a last frame in the series of frames. The duration of the tone signal may be determined based on the determined start time and end time of the tone in the signal.

Abstract: The invention includes a streptavidin mutein having at least one mutation chosen to cause one or more of steric hindrance, charge repulsion, or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues. The mutein may exist in monomeric form even in the presence of biotin, and reversibly binds to biotin. The invention also includes polynucleotides encoding such muteins, expression systems and host cells for producing such muteins. The invention also includes a method of capturing biotinylated molecules using the muteins of the invention.

Abstract: The invention includes a streptavidin mutein having at least one mutation chosen to cause one or more of steric hindrance, charge repulsion, or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues. The mutein may exist in monomeric form even in the presence of biotin, and reversibly binds to biotin. The invention also includes polynucleotides encoding such muteins, expression systems and host cells for producing such muteins. The invention also includes a method of capturing biotinylated molecules using the muteins of the invention.

Abstract: The invention includes a streptavidin mutein having at least one mutation chosen to cause one or more of steric hindrance, charge repulsion, or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues. The mutein may exist in monomeric form even in the presence of biotin, and reversibly binds to biotin. The invention also includes polynucleotides encoding such muteins, expression systems and host cells for producing such muteins. The invention also includes a method of capturing biotinylated molecules using the muteins of the invention.

Abstract: A video display terminal capable of operating with a graphical user interface such as Windows provides windowing functionality to permit use of popular applications programs resident on a server, without requiring more than application data to be transmitted from the server, and keyboard and mouse information to be transmitted from a terminal to the server. A terminal for communicating with a server includes a network interface for communicating with a server and a processor coupled to the network interface for operating with the network interface and for accessing a windows application resident on the server without executing locally the windows application resident on the server. The processor provides windowing functionality to permit use of a windows application resident on the server without requiring more than windowing information of the windows application to be transmitted from the server, wherein the windowing information includes application data.

Abstract: The invention includes a streptavidin mutein having at least one mutation chosen to cause one or more of steric hindrance, charge repulsion, or improvement of solubility by changing interfacial hydrophobic residues to less hydrophobic or hydrophilic residues. The mutein may exist in monomeric form even in the presence of biotin, and reversibly binds to biotin. The invention also includes polynucleotides encoding such muteins, expression systems and host cells for producing such muteins. The invention also includes a method of capturing biotinylated molecules using the muteins of the invention.